Alcon Drug Patent Portfolio
Alcon owns 1 orange book drug protected by 1 US patent Given below is the list of Alcon's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5635172 | Sustained release comfort formulation for glaucoma therapy | 03 Jun, 2014 | Expired |
Alcon's Family Patents
Recent FDA approvals and tentative approvals for Alcon
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Brimonidine Tartrate; Timolol Maleate |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 03 Aug, 2010 |
Alcon Drug List
Given below is the complete list of Alcon's drugs and the patents protecting them.
1. Betoptic Pilo
Betoptic Pilo is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5635172 | Sustained release comfort formulation for glaucoma therapy |
03 Jun, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Betoptic Pilo's drug page